HRP20161465T8 - Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo - Google Patents

Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Info

Publication number
HRP20161465T8
HRP20161465T8 HRP20161465TT HRP20161465T HRP20161465T8 HR P20161465 T8 HRP20161465 T8 HR P20161465T8 HR P20161465T T HRP20161465T T HR P20161465TT HR P20161465 T HRP20161465 T HR P20161465T HR P20161465 T8 HRP20161465 T8 HR P20161465T8
Authority
HR
Croatia
Prior art keywords
vivo
high density
inorganic nanoparticles
destroy cells
destroy
Prior art date
Application number
HRP20161465TT
Other languages
English (en)
Inventor
Laurent Levy
Agnès Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of HRP20161465T1 publication Critical patent/HRP20161465T1/hr
Publication of HRP20161465T8 publication Critical patent/HRP20161465T8/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
HRP20161465TT 2008-06-05 2016-11-07 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo HRP20161465T8 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (en) 2008-06-05 2008-06-05 Inorganic nanoparticles of high density to destroy cells in-vivo
US6020208P 2008-06-10 2008-06-10
PCT/EP2009/056880 WO2009147214A2 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles, preparation and uses thereof
EP09757595.5A EP2300054B1 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles of high density to destroy cells in-vivo

Publications (2)

Publication Number Publication Date
HRP20161465T1 HRP20161465T1 (hr) 2017-01-27
HRP20161465T8 true HRP20161465T8 (hr) 2017-04-21

Family

ID=39734334

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20161465TT HRP20161465T8 (hr) 2008-06-05 2016-11-07 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
HRP20181993TT HRP20181993T1 (hr) 2008-06-05 2018-11-27 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20181993TT HRP20181993T1 (hr) 2008-06-05 2018-11-27 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Country Status (26)

Country Link
US (1) US8845507B2 (hr)
EP (4) EP2130553A1 (hr)
JP (1) JP5734181B2 (hr)
KR (1) KR101639281B1 (hr)
CN (1) CN102056628B (hr)
AU (1) AU2009254550B2 (hr)
BR (1) BRPI0913410B1 (hr)
CA (1) CA2727576C (hr)
CY (2) CY1118217T1 (hr)
DK (2) DK2300054T3 (hr)
EA (1) EA023012B1 (hr)
ES (2) ES2602048T3 (hr)
HR (2) HRP20161465T8 (hr)
HU (2) HUE030669T2 (hr)
IL (1) IL209625A (hr)
LT (2) LT2300054T (hr)
MA (1) MA32453B1 (hr)
MX (1) MX2010013322A (hr)
NZ (1) NZ589888A (hr)
PL (2) PL2300054T3 (hr)
PT (2) PT3150227T (hr)
SG (1) SG10201405288WA (hr)
SI (2) SI3150227T1 (hr)
TR (1) TR201819077T4 (hr)
WO (1) WO2009147214A2 (hr)
ZA (1) ZA201100082B (hr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070164238A1 (en) * 2003-02-24 2007-07-19 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
EP2275137A1 (en) * 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
TWI572389B (zh) 2009-11-10 2017-03-01 伊穆諾萊特公司 用於產生介質中之改變之儀器組及系統、用於產生光或固化之系統、輻射固化或可固化物品、微波或rf接受器及用於治療或診斷之系統
WO2011133228A2 (en) 2010-04-23 2011-10-27 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
CN107416764A (zh) 2010-10-27 2017-12-01 皮瑟莱根特科技有限责任公司 纳米晶体的合成、盖帽和分散
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
SG11201403096VA (en) 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
AU2013274093A1 (en) * 2012-06-14 2014-12-18 Bioventures, Llc Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
BR112015017490A2 (pt) * 2013-01-25 2017-07-11 Nanobiotix uso de nanopartículas inorgânicas
EP2958553B1 (en) * 2013-02-19 2018-02-14 National Health Research Institutes Caged platinum nanoclusters for anticancer chemotherapeutics
JP6387400B2 (ja) 2013-05-30 2018-09-05 ナノビオティックスNanobiotix 医薬組成物、その製造および使用
MX2015017774A (es) * 2013-06-20 2016-03-31 Nanobiotix Composiciones y metodos para el uso en el diagnostico medico.
EP2886128A1 (en) 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
DK3229776T3 (da) 2014-11-25 2023-07-31 Curadigm Sas Farmaceutisk sammensætning, der kombinerer mindst to særskilte nanopartikler og en farmaceutisk forbindelse, fremstilling og anvendelser deraf
UA123665C2 (uk) 2014-11-25 2021-05-12 Кюрадігм Сас Фармацевтична композиція, її одержання і застосування
DK3223796T3 (da) 2014-11-25 2021-09-27 Curadigm Sas Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
AU2015352688A1 (en) 2014-11-25 2017-07-13 Nanobiotix Pharmaceutical composition, preparation and uses thereof
PT3229843T (pt) 2014-11-25 2020-03-06 Curadigm Sas Composição farmacêutica, a sua preparação e as suas utilizações
WO2016112314A1 (en) * 2015-01-08 2016-07-14 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
TW201705977A (zh) * 2015-05-28 2017-02-16 奈諾生技公司 作為治療疫苗之奈米顆粒
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
US20230211175A1 (en) * 2020-05-26 2023-07-06 Nanobiotix S.A. Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof
JP2023549698A (ja) * 2020-11-05 2023-11-29 ナノビオティックス がんの治療のためのナノ粒子の組成物
EP4255488A1 (en) * 2020-12-01 2023-10-11 Nanobiotix Porous, high-z and carbon-free particles as radioenhancers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
EP1696957A2 (en) 2003-12-17 2006-09-06 Philips Intellectual Property & Standards GmbH Radiation therapy and medical imaging using uv emitting nanoparticles
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
WO2008007290A2 (en) * 2006-07-10 2008-01-17 Philips Intellectual Property & Standards Gmbh Core-shell nanoparticles for thearapy and imaging purposes
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging

Also Published As

Publication number Publication date
KR101639281B1 (ko) 2016-07-13
MA32453B1 (fr) 2011-07-03
JP5734181B2 (ja) 2015-06-17
CN102056628B (zh) 2013-07-10
EP2130553A1 (en) 2009-12-09
EP3150227B1 (en) 2018-10-31
EA201071429A1 (ru) 2011-06-30
US20110213192A1 (en) 2011-09-01
SG10201405288WA (en) 2014-10-30
LT2300054T (lt) 2016-12-27
SI2300054T1 (sl) 2017-02-28
HRP20181993T1 (hr) 2019-01-25
JP2011524866A (ja) 2011-09-08
DK3150227T3 (en) 2019-01-14
TR201819077T4 (tr) 2019-01-21
HUE040247T2 (hu) 2019-02-28
ES2602048T3 (es) 2017-02-17
CY1121078T1 (el) 2019-12-11
EP3461502A1 (en) 2019-04-03
HRP20161465T1 (hr) 2017-01-27
ES2702249T3 (es) 2019-02-28
PL2300054T3 (pl) 2017-04-28
CA2727576C (en) 2016-08-16
AU2009254550B2 (en) 2013-10-24
CY1118217T1 (el) 2017-06-28
BRPI0913410A2 (pt) 2015-11-24
BRPI0913410B1 (pt) 2021-09-21
CN102056628A (zh) 2011-05-11
WO2009147214A3 (en) 2010-02-25
SI3150227T1 (sl) 2019-02-28
PL3150227T3 (pl) 2019-05-31
IL209625A0 (en) 2011-02-28
CA2727576A1 (en) 2009-12-10
ZA201100082B (en) 2011-10-26
NZ589888A (en) 2012-06-29
IL209625A (en) 2015-11-30
MX2010013322A (es) 2011-01-21
EP3150227A1 (en) 2017-04-05
EA023012B1 (ru) 2016-04-29
EP2300054B1 (en) 2016-09-07
AU2009254550A1 (en) 2009-12-10
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
DK2300054T3 (en) 2016-12-05
US8845507B2 (en) 2014-09-30
HUE030669T2 (en) 2017-05-29
PT3150227T (pt) 2018-12-24
EP2300054A2 (en) 2011-03-30
KR20110028616A (ko) 2011-03-21
WO2009147214A2 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
HRP20181993T1 (hr) Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
ZA201008392B (en) Treatment of pluripotent cells
EP2350770A4 (en) PROCESS FOR CONSCIOUS PERFORMANCE MANAGEMENT
EP2349918A4 (en) STABLE NANOPARTICLES AND METHODS OF PRODUCING AND USING THESE PARTICLES
SG10201401643PA (en) Methods for assessing cytotoxicity of single cells
EP2381936A4 (en) PATHS FOR GENERATING HAIR CELLS
EP2391579A4 (en) COMPOSITIONS OF SURFACE-MODIFIED NANOPARTICLES
EP2460215A4 (en) THREE-DIMENSIONAL BATTERY ARCHITECTURES AND MANUFACTURING METHOD THEREFOR
EP2379458A4 (en) SELENIZATION OF A LAYER OF PRECURSORS CONTAINING NANOPARTICLES OF HIDES2
EP2291513A4 (en) COLONY-MAKING HEMANGIOZELLES AND NONIMPLANTING HEMANGIOZELLES
EP2393930A4 (en) CELLULAR LINES EXPRESSING CFTR AND METHODS OF USE THEREOF
IL218964A0 (en) Phototriggered nanoparticles for cell and tissue targeting
GB0808965D0 (en) Equipment to stimulate photosensitized cells
IL211567A0 (en) Use of stem cells to prevent neuronal dieback
IL216842A (en) Methods for producing hybrid / chimeric cells and their uses
GB0912103D0 (en) Energy consumption monitor
GB0915732D0 (en) Improvements in or relating to exfoliation
GB0800165D0 (en) Combined hydrogen and power production
GB0910401D0 (en) Production of nanoparticles
GB201015579D0 (en) Provision of electrical energy
HK1157387A1 (en) Use of hsa-producing cells
EP2318570A4 (en) ELECTROLYTIC CELL AND RELATED METHODS FOR THE PRODUCTION AND USE THEREOF
TWM370966U (en) Structure of travel backpack
TWM371297U (en) Improved structure of power lock
TWM374201U (en) Improved structure of power connector